Atenolol 50 MG for Healthy Subjects

Phase-Based Progress Estimates
Mayo Clinic, Rochester, MNHealthy SubjectsAtenolol 50 MG - Drug
50 - 75
What conditions do you have?

Study Summary

This trial will evaluate whether atenolol prevents bone loss in postmenopausal women.

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Baseline, 24 months

Baseline, 24 months
: Percent change in femur neck bone mineral density (BMD)
: Percent changes in lumbar spine and total hip BMD

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Experimental Treatment

Non-Treatment Group

420 Total Participants · 2 Treatment Groups

Primary Treatment: Atenolol 50 MG · Has Placebo Group · Phase 3

Experimental Group · 1 Intervention: Atenolol 50 MG · Intervention Types: Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 24 months

Who is running the clinical trial?

Sundeep Khosla, M.D.Lead Sponsor
1 Previous Clinical Trials
120 Total Patients Enrolled
Columbia UniversityOTHER
1,317 Previous Clinical Trials
1,623,569 Total Patients Enrolled
64 Previous Clinical Trials
37,556 Total Patients Enrolled
University of California, San FranciscoOTHER
2,312 Previous Clinical Trials
11,757,918 Total Patients Enrolled
Sundeep Khosla, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus, Mayo Clinic Rochester
Harvard Medical Sch (Medical School)
Mass Gen Hospital (Residency)
6 Previous Clinical Trials
466 Total Patients Enrolled

Eligibility Criteria

Age 50 - 75 · Female Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
New York50.0%
How old are they?
18 - 6550.0%
What site did they apply to?
Columbia University Irving Medical Center100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria25.0%
Met criteria75.0%

How responsive is this trial?

Most responsive sites:
  1. Columbia University Irving Medical Center: < 48 hours
Typically responds via
Phone Call66.7%
Average response time
  • < 2 Days

Frequently Asked Questions

What is the scientific research community's consensus on Atenolol 50 MG?

"There are presently seven clinical trials investigating Atenolol 50 MG, with two of them being in Phase 3. The majority of the trials for Atenolol 50 MG are based in Scarborough, Maine, but there are115 locations running studies for Atenolol 50 MG in total." - Anonymous Online Contributor

Unverified Answer

Atenolol 50 MG is commonly used to manage which medical condition?

"Atenolol 50 MG is the go-to medication for treating tachycardia and ventricular. However, it can also help patients that suffer from angina pectoris, coronary artery atherosclerosis, and bradycardia." - Anonymous Online Contributor

Unverified Answer

Does this experiment require participants to be over 25 years old?

"The age range that this clinical trial is accepting patients is between 50-75 years old." - Anonymous Online Contributor

Unverified Answer

Are enrollees still being accepted for this experiment?

"The listing for this clinical trial on confirms that it is still recruiting participants. The trial was first posted on 7/27/2021 and was last updated on 8/15/2022." - Anonymous Online Contributor

Unverified Answer

Could I take part in this scientific research?

"Investigators are looking for 420 individuals aged 50-75 who currently have healthy subjects (hs). The following inclusion criteria must also be met: Aged 50-75 years." - Anonymous Online Contributor

Unverified Answer

How many participants are being allowed into this clinical trial?

"That is correct. If you visit, you will see that this trial was initially posted on July 27th, 2021 and updated as recently as August 15th, 2022. The study requires 420 individuals from 3 different locations." - Anonymous Online Contributor

Unverified Answer

Has Atenolol 50 MG received FDA approval?

"Atenolol 50 MG ranks a 3 on our Power scale because it is a Phase 3 medication. This signifies that, while there is data supporting its efficacy, there are also multiple rounds of data supporting its safety." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.